Exclusive: OpenAI has acquired Orchestra Bio
OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios.
Axios AI+2 min read
1 story
OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios.
Showing 1 of 1 stories
You're all caught up.
Get the top AI news and tools straight to your inbox every week.
Weekly · AI news
Join 15,000+ AI enthusiasts